J&J to Resume Shipments of COVID-19 Vaccine to EU with Safety Warning
Johnson & Johnson said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region’s medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots.
Europe’s health regulator, the European Medicines Agency (EMA), on Tuesday recommended adding a warning about rare blood clots with low blood platelet count to the vaccine’s product label and said the benefits of the one-dose shot outweigh its risks.
Use of the J&J vaccine was temporarily halted by U.S. regulators last week after rare brain blood clots combined with a low blood platelet count were reported in six women, prompting the company to delay its rollout in Europe.
Johnson & Johnson to resume rollout of coronavirus vaccine in Europe with safety warning
geo.tv - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geo.tv Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson reanudará la distribución de la vacuna contra el COVID-19 en Europa con una advertencia en la etiqueta - Monumental
monumental.co.cr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from monumental.co.cr Daily Mail and Mail on Sunday newspapers.
Big jumps in sales of prescription drugs and medical devices helped Johnson & Johnson boost its first-quarter profit nearly 7 per cent, blowing past Wall Street forecasts. The health care giant on Tuesday raised and narrowed its financial forecasts for 2021, and its shares jumped more than 2 per cent in midday trading. The one weak spot was a small drop in consumer health sales, which saw a surge in 2020 s first quarter, when nervous consumers stocked up on over-the-counter medicines and hygiene products as the coronavirus pandemic set in and lockdowns began. Meanwhile, Johnson & Johnson last week paused administration of its COVID-19 vaccine, due to worries over roughly one in a million vaccine recipients developing unusual blood clots along with low blood levels. One of them died.